1. Home
  2. TNXP vs VTSI Comparison

TNXP vs VTSI Comparison

Compare TNXP & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • VTSI
  • Stock Information
  • Founded
  • TNXP 2007
  • VTSI 1993
  • Country
  • TNXP United States
  • VTSI United States
  • Employees
  • TNXP N/A
  • VTSI N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • TNXP Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • TNXP 118.2M
  • VTSI 45.2M
  • IPO Year
  • TNXP N/A
  • VTSI N/A
  • Fundamental
  • Price
  • TNXP $18.94
  • VTSI $4.60
  • Analyst Decision
  • TNXP Strong Buy
  • VTSI Strong Buy
  • Analyst Count
  • TNXP 2
  • VTSI 2
  • Target Price
  • TNXP $585.00
  • VTSI $13.00
  • AVG Volume (30 Days)
  • TNXP 590.0K
  • VTSI 67.1K
  • Earning Date
  • TNXP 05-20-2025
  • VTSI 05-12-2025
  • Dividend Yield
  • TNXP N/A
  • VTSI N/A
  • EPS Growth
  • TNXP N/A
  • VTSI N/A
  • EPS
  • TNXP N/A
  • VTSI 0.12
  • Revenue
  • TNXP $10,094,000.00
  • VTSI $26,350,819.00
  • Revenue This Year
  • TNXP $12.17
  • VTSI N/A
  • Revenue Next Year
  • TNXP $789.15
  • VTSI $22.35
  • P/E Ratio
  • TNXP N/A
  • VTSI $37.08
  • Revenue Growth
  • TNXP 29.94
  • VTSI N/A
  • 52 Week Low
  • TNXP $6.76
  • VTSI $3.57
  • 52 Week High
  • TNXP $672.00
  • VTSI $17.68
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 53.83
  • VTSI 54.70
  • Support Level
  • TNXP $18.55
  • VTSI $4.23
  • Resistance Level
  • TNXP $21.99
  • VTSI $4.61
  • Average True Range (ATR)
  • TNXP 1.51
  • VTSI 0.32
  • MACD
  • TNXP 0.27
  • VTSI 0.10
  • Stochastic Oscillator
  • TNXP 60.18
  • VTSI 77.44

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: